NASDAQ:AERI

Aerie Pharmaceuticals Earning Date

USA |NASDAQ |USD

AERI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.62 $-0.67 $-0.65
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $28.99M $27.18M $20.08M

Aerie Pharmaceuticals's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

AERI Earnings Date & History Chart

AERI Earnings & Revenue Forecast

AERI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-0.60 $-0.79 $-0.48
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-2.56 $-2.88 $-2.42
Dec 2022 8 $-1.75 $-2.51 $-0.83

AERI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-0.59 $-0.59 $-0.52
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-2.54 $-2.55 $-2.44
Dec 2022 0 / 1 $-1.65 $-1.62 $-1.42

AERI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $32.00M $29.59M $34.80M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $111.44M $107.50M $115.00M
Dec 2022 11 $161.77M $144.41M $193.00M

AERI Earnings Date & Revenue History

AERI Earnings History

|
Show More
Show More

AERI Revenue History

|
Show More
Show More

Aerie Pharmaceuticals Next Earnings Date & Report

AERI Next Earnings Date & Report Preview: Sep 2021 (FQ)

AERI's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 8 analysts, the average EPS estimation for Aerie Pharmaceuticals's next quarterly earnings is $-0.62, with a low EPS estimation of $-0.71, and a high estimation of $-0.57.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $-0.62, the last 2 month trend is $-0.62, and the 3 month trend is $-0.59.

Based on 11 analysts, the average revenue estimation is $28.99M, with a low revenue estimation of $27.75M, and a high estimation of $30.50M.

Aerie Pharmaceuticals Previous Earnings Dates & Reports

AERI Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aerie Pharmaceuticals's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

AERI's earnings per share (EPS) was $-0.67, missing the consensus analysts forecast of $-0.65 by -3.08%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -6.94%, and higher than the same period a year before (Jun 2020) by -19.14%.

Revenues were $27.18M, better than the forecast of $27.18M by 0.00%, up by 18.35% from the previous quarter , and up by 50.75% from the same period last year.

The company reported a net income of $-38.69M.

Free cash flow for the quarter was $-20.75M , compared to $-30.83M last quarter and $-23.32M a year before.

AERI ended the quarter with $235.94M in total debt, an increase of 2.56% compared to the previous quarter, and an increase of 15.39% compared to the same quarter a year before.

AERI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aerie Pharmaceuticals's previous annual earnings date was Feb 26, 2021 for its fiscal year ended Dec 31, 2020.

AERI's earnings per share (EPS) was $-3.11, missing the consensus analysts forecast of $-2.98 by 4.51% , and higher than the previous year's EPS (Dec 2019) by -8.40%.

Revenues were $83.14M, better than the forecast of $83.14M by 0.00%, and up by 18.96% from previous year's revenue.

The company reported a net income of $-183.10M.

Aerie Pharmaceuticals reported a free cash flow of $-67.79M for its fiscal year, compared to $-160.39M a year ago.

The company ended the fiscal year with $215.30M in total debt, an increase of 10.89% compared to the previous year.